Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 31 to 43 of 43 results for brachytherapy

  1. Prostate cancer (QS91)

    This quality standard covers managing prostate cancer in people referred to secondary care or having follow-up for prostate cancer in primary care. It describes high-quality care in priority areas for improvement.

    Quality standard
    Last updated
    30 December 2021
    View quality statements

    Sections for QS91

  2. Photodynamic therapy for localised inoperable endobronchial cancer (IPG137)

    Evidence-based recommendations on photodynamic therapy (PDT) for localised inoperable endobronchial cancer (non-small-cell lung cancer). This involves injecting a photosensitising agent into the body that is activated by laser light to destroy the cancerous tissue.

    Interventional procedures guidance
    Published
    23 November 2005
    View recommendations

    Sections for IPG137

  3. Irreversible electroporation for treating primary lung cancer and metastases in the lung (IPG441)

    Evidence-based recommendations on irreversible electroporation for treating primary lung cancer and metastases in the lung. This involves using electrical pulses to kill cancer cells.

    Interventional procedures guidance
    Published
    23 February 2013
    View recommendations

    Sections for IPG441

  4. Percutaneous radiofrequency ablation for primary or secondary lung cancers (IPG372)

    Evidence-based recommendations on percutaneous radiofrequency ablation for primary or secondary lung cancers. This involves inserting one or more electrodes (needle-like probes) through the chest into the lung and using an electrical current to produce heat to destroy the cancer cells.

    Interventional procedures guidance
    Published
    15 December 2010
    View recommendations

    Sections for IPG372

  5. Intrabeam radiotherapy system for adjuvant treatment of early breast cancer (TA501)

    Evidence-based recommendations on using Intrabeam radiotherapy during breast-conserving surgery in adults.

    Technology appraisal guidance
    Published
    31 January 2018
    View recommendations

    Sections for TA501

  6. Focal therapy using cryoablation for localised prostate cancer (IPG423)

    Evidence-based recommendations on focal therapy using cryoablation for localised stage prostate cancer. This involves using freezing (cryotherapy) needles to find and destroy only the cancerous part of the prostate.

    Interventional procedures guidance
    Published
    26 April 2012
    View recommendations

    Sections for IPG423

  7. ProKnow cloud-based system for radiotherapy data storage, communication and management: early value assessment (HTE5)

    Early value assessment (EVA) guidance on the ProKnow cloud-based system for radiotherapy data storage, communication and management....

    Health technology evaluation
    Last updated
    14 March 2024
    View recommendations

    Sections for HTE5

  8. Artificial intelligence technologies to aid contouring for radiotherapy treatment planning: early value assessment (HTE11)

    Early value assessment (EVA) guidance on artificial intelligence technologies to aid contouring for radiotherapy treatment planning in people having external be...

    Health technology evaluation
    Published
    27 September 2023
    View recommendations

    Sections for HTE11

  9. Preoperative high dose rate brachytherapy for rectal cancer (IPG201)

    This guidance has been updated and replaced by NICE interventional procedures guidance 531.

    Interventional procedures guidance
    Published
    13 December 2006

  10. superDimension Navigation System to help diagnostic sampling of peripheral lung lesions (MIB194)

    NICE has developed a medtech innovation briefing (MIB) on superDimension Navigation System to help diagnostic sampling of peripheral lung lesions .

    Medtech innovation briefing
    Published
    11 October 2019

  11. Early and locally advanced breast cancer: diagnosis and management (NG101)

    This guideline covers diagnosing and managing early and locally advanced breast cancer. It aims to help healthcare professionals offer the right treatments to people, taking into account the person's individual preferences.

    NICE guideline
    Last updated
    16 January 2024
    View recommendations

    Sections for NG101

  12. Research recommendations

    CG175/2 | Androgen deprivation therapy and/or brachytherapy added to radiotherapy for men with intermediate- and high-risk localised

  13. NICE real-world evidence framework (ECD9)

    The NICE real-world evidence framework aims to improve the quality of real-world evidence informing our guidance. The framework does not set minimum standards for the acceptability of evidence. The framework is mainly targeted at those developing evidence to inform NICE guidance. It is also relevant to patients, those collecting data, and reviewers of evidence